Abbott Gains FDA Clearance For Lab-Based Concussion Test
Abbott said it received the US FDA nod to run its blood-based test to assess patients for concussions on its Alinity i laboratory instrument. This will make the test more widely available in hospitals and laboratories in the US.
You may also be interested in...
CES 2023: Abbott, Seth Rogen, An Avatar For Old Folks, And A Smart Toilet For The Heartbroken
In this first roundup of innovative digital health solutions showcased at CES 2023, Medtech Insight highlights Abbott’s award-winning tech, an AARP-sponsored panel discussion on Alzheimer’s with Seth and Lauren Miller Rogen, Care.coach, and Casana, a smart toilet for monitoring patients with heart disease.
Abbott Collaborates With U.S. Military On Head Injury Diagnostic
The U.S Department of Defense announced a collaboration Abbott to develop portable blood tests to help evaluate potential concussions that will run on for Abbott's i-STAT point-of-care testing system.
Becton Dickinson Receives FDA Clearance For Vaginal Panel To Detect Vaginitis
BD said its newly FDA-cleared Vaginal Panel can detect three most common infectious causes of vaginitis with a single swab, reducing the need for repeat testing.